TrialPloS one2009

Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.

Melissa C Paoloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.